PARIS — L’Oréal has taken a minority stake in Swiss longevity biotech company Timeline.
Terms of the deal, which was made through the wonder giant’s strategic enterprise capital fund Business Opportunities for L’Oréal Development, weren't disclosed.
Timeline was founded in 2007 by Chris Rinsch and Patrick Aebischer as a by-product of the Swiss Federal Institute of Technology. It develops solutions for longevity within the food, business and health categories.
Rinsch serves as Timeline president, and Aebischer is its chairman.
“Timeline has developed a proprietary molecule, Mitopure, that recycles and rejuvenates aging mitochondria, the powerhouses of cells,” L’Oréal said in a press release Tuesday. “This breakthrough technology is backed by greater than a decade of research by distinguished scientists, multiple gold standard clinical studies and an unparalleled...
Continue reading
0 Comments
